0001188290-14-000001.txt : 20140606 0001188290-14-000001.hdr.sgml : 20140606 20140605175306 ACCESSION NUMBER: 0001188290-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140606 DATE AS OF CHANGE: 20140605 EFFECTIVENESS DATE: 20140606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NAPO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001188290 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-218681 FILM NUMBER: 14894561 BUSINESS ADDRESS: STREET 1: 185 BERRY STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 185 BERRY STREET, SUITE 1300 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0707 D LIVE 0001188290 NAPO PHARMACEUTICALS INC 185 BERRY STREET, SUITE 1300 SAN FRANCISCO CA CALIFORNIA 94107 415-371-8300 DELAWARE PS Pharmaceuticals, Inc. None Corporation true Lisa Conte 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Executive Officer Director Steven King 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Executive Officer Joshua Mailman 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Director Richard Fields 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Director Gregory Stock 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Director Thomas Van Dyck 185 Berry Street, Suite 1300 San Francisco CA CALIFORNIA 94107 Director Pharmaceuticals Decline to Disclose 06b false 2014-03-18 false true true true true Warrants and the underlying common stock issuable upon exercise thereof false 0 137500 137500 0 false 3 0 0 0 false NAPO PHARMACEUTICALS INC /s/ Lisa Conte Lisa Conte CEO 2014-06-03